Rs. 270.00 per
10 s per pack
The most common adverse reactions associated with Empagliflozin or greater incidence) were urinary tract infections and female genital mycotic infections.
History of serious hypersensitivity reaction to empagliflozin or any of the excipients in VORETA. Severe renal impairment, end-stage renal disease, or dialysis.
Volume Depletion: Before initiating VORETA, assess volume status and renal function in patients with impaired renal function, elderly patients, or patients on loop diuretics. Monitor for signs and symptoms during therapy.
Urosepsis and Pyelonephritis: Evaluate patients for signs and symptoms of urinary tract infections and treat promptly, if indicated.
This Medicine should not be use in Pregnancy.
It is to be used in with caution along Diuretics & Insulin or Insulin Secretagogues.